ProAxsis

Pharmaceutical ManufacturingNorthern Ireland, United Kingdom2-10 Employees

ProAxsis Limited operates as a global diagnostics company focused on measuring active protease biomarkers, with a product portfolio that enables detection of active proteases in complex biological samples and provides a visual readout of their presence. Its offerings include activity-based assays and related biomarkers, such as neutrophil elastase and proteinase 3, which are targeted as indicators of lung infection and inflammation in chronic respiratory diseases. The company has developed a point-of-care option, NEATstik, to support ongoing monitoring of active neutrophil elastase levels, and maintains expertise in additional inflammatory markers including IL-6, IL-8 and TNF-alpha. In addition to supplying assays, ProAxsis provides sample analysis services from its Belfast laboratory and supports pharmaceutical sponsor-led clinical trials across various phases. Based in Northern Ireland, the business operates within the pharmaceutical manufacturing sector and serves a growing list of pharmaceutical and academic customers worldwide. Recent developments include partnerships and initiatives aimed at expanding remote respiratory monitoring capabilities and sustaining ongoing research collaborations.

Sign up for free to view info

Email Format Employee directory